<DOC>
	<DOC>NCT00297128</DOC>
	<brief_summary>- feasibility and tolerance of preoperative therapy with Cetuximab in combination with Capecitabine and radiotherapy for patients with locally advanced operable rectal carcinoma - collection of response rate (T-downstaging, pathological complete remission), correlation of responsiveness with EGFR-status</brief_summary>
	<brief_title>Preoperative Chemoradiation With Capecitabine and Cetuximab</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Age: 1880 bioptical confirmed adenocarcinoma of the rectum in operable T3T4NxM0 status. In spite of infiltration of the neighbouring organs the tumor has to be basically surgically complete resectable no former chemotherapy, radiotherapy of pelvis or abdomen and/or tumor resection of a rectum carcinoma WHO performance status 02 adequate bone marrow reserve (granulocytes not more than 1.500/µl; thrombocytes not more than 100.000/µl) adequate hepatic function ( bilirubin not more than 1.5 x ULN; GOT and GPT not more than 3.5 x ULN) adequate renal function (creatinin not more than 1.5 mg/dl) women of childbearing potential: exclusion of pregnancy (negative urin or serum pregnancy test) willingness of women of childbearing potential and accordingly of potent men to use approved contraceptives (e.g. birthcontrol pill, loop, condom) during and at least 3 month after conclusion of the study life expectancy of at least 3 month signed Informed Consent before recruitment exclusion of distant metastases at the time of recruitment former radiotherapy of pelvis or abdomen former chemotherapy any other kind of malign tumor (except adequate treated skin basalioma or in situ cervical carcinoma) in the last 5 years general contraindication or known hypersensitivity against Cetuximab and/or Capecitabine Non malign disease, if there is a contraindication with radiotherapy or chemotherapy with Cetuximab and Capecitabine or a resection of the rectum: highgraded cardiac insufficiency, angina pectoris, hypertension or arrhythmia, hepatic disease, significant neurological or psychiatric disorders florid, serious infections at the time of recruitment legally limited contractual capability or evidence of neurological or psychiatric disease, if it will constrict the patients compliance in the opinion of the investigator evidence of lacking cooperation of the patient pregnant or breast feeding women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>pilot study</keyword>
	<keyword>rectal</keyword>
	<keyword>cancer</keyword>
	<keyword>phase II</keyword>
	<keyword>preoperative</keyword>
	<keyword>chemoradiation</keyword>
	<keyword>capecitabine</keyword>
	<keyword>cetuximab</keyword>
	<keyword>operable</keyword>
	<keyword>T4</keyword>
	<keyword>ABCSG</keyword>
	<keyword>TAKO</keyword>
	<keyword>R03</keyword>
	<keyword>96</keyword>
	<keyword>06</keyword>
</DOC>